Genolution Inc. (KOSDAQ:225220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,445.00
+28.00 (1.98%)
At close: Aug 12, 2026

Genolution Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
9,8219,4047,1369,76138,085
Revenue Growth
23.67%31.79%-26.90%-74.37%-
Gross Profit
3,6913,4422,3004,45725,907
Operating Income
-7,539-8,642-9,164-7,09114,737
Net Income
-8,968-11,643-6,826-5,51214,602
Earnings Per Share
-496.38-644.48-378.00-300.43768.91
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
27,56627,91933,22043,46446,390
Total Debt
24,06624,03424,27024,14816,885
Net Cash (Debt)
3,4993,8868,95019,31629,504
Net Cash Growth
-63.53%-56.58%-53.67%-34.53%-
Net Cash Per Share
193.69215.09495.631052.901563.01

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-5,072-7,012-1,433-1,13613,551
Capital Expenditures
-373.59-296.3-12,125-6,805-22,506
Free Cash Flow
-5,445-7,308-13,558-7,940-8,955
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
37.58%36.60%32.23%45.66%68.03%
Operating Margin
-76.76%-91.89%-128.42%-72.65%38.70%
Pretax Margin
-100.71%-133.83%-94.89%-68.16%45.26%
Profit Margin
-91.31%-123.80%-95.65%-56.46%38.34%
FCF Margin
-55.44%-77.71%-190.00%-81.34%-23.51%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
----5.97
PS Ratio
2.613.655.637.542.29